Inhibition of BRD4 enhanced the tumor suppression effect of dasatinib in gastric cancer

BRD4, a member of the bromodomain and extraterminal (BET) family, is elevated in multiple cancer tissues, including gastric cancer (GC). Targeted therapy with BRD4 may help improve the overall survival of patients with GC. Meanwhile, the approved multi-target kinase inhibitor, dasatinib, was recentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Hao, Hu, Xuefei, Yang, Xinrui, Chen, Jiahui, Fu, Yating, He, Hongwei, Shi, Yongkang, Zeng, Rong, Chang, Wenjun, Zheng, Shangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646567/
https://www.ncbi.nlm.nih.gov/pubmed/36352160
http://dx.doi.org/10.1007/s12032-022-01831-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646567/
https://www.ncbi.nlm.nih.gov/pubmed/36352160
http://dx.doi.org/10.1007/s12032-022-01831-8

Ejemplares similares